enVVeno Medical (NVNO) Enterprise Value (2017 - 2026)

enVVeno Medical's Enterprise Value history runs 10 years deep, the most recent figure standing at -$24.9 million for Q1 2026.

• On a quarterly basis, Enterprise Value rose 35.98% year-over-year to -$24.9 million in Q1 2026; TTM through Mar 2026 was -$24.9 million, a 35.98% increase from a year earlier, with the FY2025 full-year figure at -$28.2 million, up 34.62% from the prior year.
• Enterprise Value improved to -$24.9 million in Q1 2026 per NVNO's latest filing, from -$28.2 million in the prior quarter.
• Across five years, Enterprise Value topped out at -$24.9 million in Q1 2026 and bottomed at -$51.3 million in Q1 2022.
• The 5-year median for Enterprise Value is -$38.9 million (2025), against an average of -$37.4 million.
• Across the five-year window, Enterprise Value surged 36.28% in 2023 and slumped 88.27% in 2024, its largest moves.
• Year by year, Enterprise Value stood at -$39.0 million in 2022, then fell by 18.87% to -$46.4 million in 2023, then grew by 7.02% to -$43.2 million in 2024, then jumped by 34.62% to -$28.2 million in 2025, then increased by 11.63% to -$24.9 million in 2026.
• Per Business Quant, the three latest NVNO Enterprise Value figures stand at -$24.9 million (Q1 2026), -$28.2 million (Q4 2025), and -$31.0 million (Q3 2025).